|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.34 SEK | +1.13% |
|
-48.06% | -49.05% |
NextCell Pharma AB reported earnings results for the fourth quarter ended August 31, 2023. For the fourth quarter, the company reported sales was SEK 2.76 million compared to SEK 1.35 million a year ago. Revenue was SEK 3.95 million compared to SEK 1.41 million a year ago.
Net loss was SEK 8.64 million compared to SEK 8.56 million a year ago. Basic loss per share from continuing operations was SEK 0.25 compared to SEK 0.25 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -49.05% | 4.19M | |
| +0.67% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +6.55% | 24.63B | |
| -21.66% | 18.2B | |
| +29.96% | 12.01B | |
| -1.57% | 11.76B | |
| +16.03% | 10.4B | |
| -4.80% | 9.94B |
NEXTCELL PHARMA AB 
